The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Biocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

As per the agreement, Rhizen will receive an undisclosed upfront cash payment and is eligible to receive additional development and commerc...

New Delhi, June 30 (IANS) The National Biopharma Mission aimed at accelerating biopharmaceutical development in the country was launched by...

The ministry, which has received a loan of $125 million (over Rs 800 crore) from the World Bank for its “Innovate in India” (i3) program, h...

GE Healthcare said that it has reached an agreement to acquire PAA Laboratories that develops and supplies cell culture media for biomedica...

Samsung Electronics, the world's biggest manufacturer of flat screen televisions and computer memory chips, will hold 40 per cent of the ve...

Biocon's third quarter consolidated net profit rose 24% to 100.75 helped by inflows from licensing deals with global biggies Pfizer and Myl...

Reliance Life Sciences (RLS), a company promoted by Reliance Industries’ chairman, Mukesh Ambani, is looking at biopharmaceuticals as a hug...

A clutch of investors are set to pick up 47% stake in the Intas Biopharmaceuticals, the biotech arm of Ahmedabad-based pharma major Intas P...

Intas Biopharmaceuticals Ltd (IBPL) has received European Union-good manufacturing practices (EU-GMP) certification for its manufacturing f...